Marker Therapeutics, Inc. (MRKR) Social Stream



Marker Therapeutics, Inc. (MRKR): $2.70

0.06 (+2.27%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MRKR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 449

in industry

MARKER THERAPEUTICS INC (MRKR) Price Targets From Analysts

Use the tables below to see what analysts covering MARKER THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 4 $8 $5.5 $6.375 $2.79 128.49%
2022-02-04 4 $8 $3 $5.625 $2.79 101.61%
2022-02-23 4 $6 $1 $4 $2.79 43.37%
2022-03-18 4 $5 $1 $3.75 $2.79 34.41%
2022-05-13 4 $5 $1 $3.625 $2.79 29.93%
2022-05-16 1 $40 $40 $40 $2.79 1333.69%
2022-08-11 4 $5 $1 $2.875 $2.79 3.05%
2022-11-10 3 $4 $1 $2.166 $2.79 -22.37%

Price Target Last Issued May 16, 2022

MRKR reports an average of 1,954.03% for its upside potential over the past 40 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-13 4 5 1 3.625 0.329 1001.82%
2022-05-16 4 40 40 40.000 0.310 12803.23%
2022-05-27 4 5 1 2.875 0.300 858.33%
2022-08-11 4 5 1 2.875 0.449 540.31%
2022-11-10 2 4 1 2.500 0.381 556.17%

MRKR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The Trend in the Broker Recommendations


MRKR's average broker recommendation rating worsened by 0.34 over the prior 24 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, MARKER THERAPEUTICS INC's average analyst price target is greater than 68.86% of them.
  • MARKER THERAPEUTICS INC's variance in analysts' estimates is lower than -672.98% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, MARKER THERAPEUTICS INC's number of analysts covering the stock is greater than 153.52% of them.
  • In terms of how MARKER THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 307.32% of that group.

In the Pharmaceutical Products industry, CALA, RLMD, and NEPT are the three stocks most similar to MARKER THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is MRKR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5618 seconds.